Blog

Autologous vs Allogeneic: Tailoring Biologic Manufacturing

In advanced medicine, the distinction between autologous and allogeneic sources is foundational—not just in clinical care, but throughout drug development and pharmaceutical manufacturing. While most commonly referenced in cell and gene therapy, these concepts impact a broad array of biologic […]

Connecting Development Expertise with Global Manufacturing

In today’s competitive CDMO landscape, the ability to offer integrated, flexible, and high-quality services across development and manufacturing is more important than ever. At Adragos, our development site in Athens plays a central role in enabling such synergy, acting as […]

Subscribe to our newsletter!

Get notified on our latest news.